Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
about
Hematopoietic stem cell transplantation: a global perspectiveRisk factors for relapse after allogeneic transplantation in acute myeloid leukemiaAn update of current treatments for adult acute myeloid leukemiaAllogeneic stem cell transplantation in first complete remissionProgress in acute myeloid leukemiaMilestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsNovel therapeutic options in Acute Myeloid Leukemia'Acute myeloid leukemia: a comprehensive review and 2016 update'Novel Prognostic and Therapeutic Mutations in Acute Myeloid LeukemiaFavorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenEx vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.Molecular therapy for acute myeloid leukaemia.Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationValue of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigenPrognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.Advances in treating acute myeloid leukemia.Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remissionDual processing model of medical decision-making.A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique.Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.The EBMT Risk Score in the Presence of Graft Versus Host Disease in Allogeneic Stem Cell Transplantation in Adult Acute Myelogenous Leukemia: A Multistate Model for Competing RisksAllogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networThe treatment of elderly patients with acute myeloid leukemia.Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective StudiesReduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia.Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.Survival analysis in hematologic malignancies: recommendations for clinicians
P2860
Q24624697-1C87C4C8-A09F-4CF0-A776-4C47CA2F338EQ26771438-E0D8A47D-5A17-461A-A079-322E1EB71655Q26776396-9A3BDAF4-2478-42A0-ACA3-80F3EC39A256Q26996818-D02DC3E0-412B-4AAD-AD15-BC4413DBB87CQ27024006-EE3E27A0-76A1-45A8-A5A3-93EDAB9CDBAEQ28067102-AC72E98D-6AA4-409B-BAFB-B7B9E8942441Q28069889-1DBC573C-1010-4ED8-9AFE-73138082D9F6Q28072539-B0E495D5-0490-43BE-BBF0-499C8D96415FQ28075654-5D6D0D6C-2948-488B-B6BF-8273D62511BDQ30315865-A22927CB-A124-4B72-A6BF-5D1447869939Q31052875-CE8F4C8D-2F9D-433F-AF26-16A4037EC775Q33555627-59296404-EAA7-4C55-9684-E0ACD9148EECQ33645271-72BED86D-98B4-4A4F-A3C1-014CE74620B6Q33760933-B74DC413-B74B-48F8-92E7-17C71DAD0C14Q33832709-A1815612-6D86-41A3-B252-924D2FEA8AA4Q33841129-78FB89CF-B3FF-4DFA-8D21-81B640B23804Q33925672-A38C7E23-7698-46D2-9064-3EB16CC92C08Q34033553-51EFB4A4-3267-48F3-A1F1-9BA710DC30DFQ34166581-D4E14321-B5F5-487A-B2A0-70E2CB8EEAABQ34167404-2D63E9C7-760E-4097-B1B6-CB8F283AF5A6Q34243434-9B245751-814B-4D13-8A78-5C858A582F48Q34255090-E130EBA4-389D-4E5F-A4CE-372914F163C4Q34312351-92006CB6-1D33-48A7-8662-AC444152DB62Q34401926-46AEB1AA-B355-43EA-869A-2C8F49A2D022Q34401953-F82991AF-17CF-48D9-9498-A99E8DDDDB1BQ34568446-6626D21B-A57F-405C-9FA9-10230C410440Q34608688-4D534A36-76F0-4711-8CFD-9794CC04EDABQ34620456-9771CFA4-D556-4510-A165-67150AC6E3B1Q34655572-1C6CB599-0C47-4BC9-B55C-D93AB45C6668Q34877613-4D820B3B-631A-42E9-B7E9-6030812AF3F9Q35009266-5B6B433F-4EBD-40A8-8508-121F72B95A08Q35082499-BC5B9AB1-9CA3-4AA2-9347-C17643894CFDQ35148420-1A3BD6A1-C5DA-4C5C-A4E2-D5CE00B6B476Q35673578-F8C736B5-1C07-4CAC-ACB2-63503E8EC4BFQ35703480-861D2C85-F9A6-4EB3-9467-D26349DBC272Q35800814-05512A04-DCBE-4C05-BAB7-B555B65A32D3Q35921388-931E2CE8-5BA0-40AA-84A6-C8DF66577839Q35953348-B8FF0B18-69BF-417D-A418-C7AD28AFC1EFQ36006412-D7F7E72D-40DE-4485-9F02-0EA3FE9D4F85Q36036279-1287B206-3A05-40E6-B94B-AA8478854E30
P2860
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@ast
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@en
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@nl
type
label
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@ast
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@en
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@nl
prefLabel
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@ast
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@en
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@nl
P2093
P1433
P1476
Results of a HOVON/SAKK donor ...... ged adults: benefits for whom?
@en
P2093
Augustin Ferrant
Emanuel Jacky
Hans van der Lelie
Harry Schouten
Jan J Cornelissen
Johan Maertens
Leo F Verdonck
Marinus van Marwijk Kooy
Martin Fey
Matthias Theobald
P304
P356
10.1182/BLOOD-2006-06-025627
P407
P577
2007-01-09T00:00:00Z